Yamazaki T
First Department of Internal Medicine, Nagoya University School of Medicine.
Rinsho Ketsueki. 1995 Apr;36(4):299-302.
Protein S is a plasma glycoprotein, which functions as a cofactor for activated protein C in the protein C pathway and also directly inhibits factors Va and Xa, independently of protein C. In plasma, protein S circulates as a free molecule (40%) or in a complex with C4b-binding protein (60%). Only a free protein S acts as an anticoagulant and its activity is lost by binding to C4b-binding protein. The physiological importance of protein S has been established by observations in patients with hereditary protein S deficiency who have an increased risk of developing thrombosis. Several previous studies reported that hereditary protein S deficiency was as common as protein C deficiency and that approximately 5% of hereditary thrombophilia was caused by protein S deficiency. But molecular biological analysis of protein S deficiency is not as advanced as protein C deficiency because the genetic characterization of protein S deficiency is limited by the presence of the inactive pseudogene that is highly homologous to the active true gene. Only a few previous studies have examined the genetic features of hereditary protein S deficiency. Further investigation is needed to characterize the pathophysiology and molecular basis of hereditary protein S deficiency.
蛋白S是一种血浆糖蛋白,在蛋白C途径中作为活化蛋白C的辅因子发挥作用,并且还能独立于蛋白C直接抑制因子Va和Xa。在血浆中,蛋白S以游离分子形式(40%)或与C4b结合蛋白形成复合物的形式(60%)循环。只有游离的蛋白S具有抗凝作用,其活性会因与C4b结合蛋白结合而丧失。通过对遗传性蛋白S缺乏症患者的观察,已证实蛋白S具有重要的生理意义,这类患者发生血栓形成的风险增加。此前的多项研究报告称,遗传性蛋白S缺乏症与蛋白C缺乏症一样常见,约5%的遗传性血栓形成倾向是由蛋白S缺乏症引起的。但对蛋白S缺乏症的分子生物学分析不如蛋白C缺乏症那样深入,因为蛋白S缺乏症的基因特征受到与活性真基因高度同源的无活性假基因的限制。此前仅有少数研究对遗传性蛋白S缺乏症的基因特征进行过研究。需要进一步研究以明确遗传性蛋白S缺乏症的病理生理学和分子基础。